Schedule 13G ownership disclosure
Orexigen Therapeutics, Inc.
Security class unavailable · CUSIP: 686164104
Event date: 2016-07-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-16-005182
- Form type
- SC 13G
- Filer
- BIOTECHNOLOGY VALUE FUND L P
- CIK
- CIK 918923
- Filed
- Jul 19, 2016
- Reporting period
- Jul 08, 2016
- Description
- Schedule 13G beneficial ownership